Atossa announces appointment of Parks as VP, Investor, Public Relations
PremiumThe FlyAtossa announces appointment of Parks as VP, Investor, Public Relations
2M ago
Texas probes CenterPoint, Carlyle weighs Nobian sale: Monday Buzz
Premium
The Fly
Texas probes CenterPoint, Carlyle weighs Nobian sale: Monday Buzz
2M ago
Texas probes CenterPoint, Starbucks in talks with Elliott: Morning Buzz
Premium
The Fly
Texas probes CenterPoint, Starbucks in talks with Elliott: Morning Buzz
2M ago
Atossa Therapeutics set to join Russell 3000 Index
PremiumThe FlyAtossa Therapeutics set to join Russell 3000 Index
4M ago
Atossa Therapeutics announces support for Phase 2 SMART study
Premium
The Fly
Atossa Therapeutics announces support for Phase 2 SMART study
4M ago
Atossa announces last patient, last dose in Phase 2 Karisma-Endoxifen trial
Premium
The Fly
Atossa announces last patient, last dose in Phase 2 Karisma-Endoxifen trial
5M ago
Atossa announces expanded research agreement with Weill Cornell Medicine
PremiumThe FlyAtossa announces expanded research agreement with Weill Cornell Medicine
5M ago
Atossa Therapeutics, Quantum Leap announces initiation of I-SPY 2 trial
Premium
The Fly
Atossa Therapeutics, Quantum Leap announces initiation of I-SPY 2 trial
6M ago
Atossa Therapeutics presents data from 40mg cohort of Phase 2 EVANGELINE trial
Premium
The Fly
Atossa Therapeutics presents data from 40mg cohort of Phase 2 EVANGELINE trial
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100